Suzhou Pharmaceutical R&D Center easy to operate Metal Expansion Joint Contract, Shanghai Songjiang Shock Absorber Group Co., Ltd. provides high-quality Excellent damping Metal Expansion Joint for Heating, ventilation, and air conditioning as well as drinking water and wastewater
1. Introduction of Suzhou Ascent International High-end Original New Small Molecule Targeted Antitumor Drug R&D, Production and Construction Project:
Project Name: Suzhou Ascent International High-end Original New Small Molecule Targeted Antitumor Drug R&D, Production and Construction Project
Project introduction: Suzhou Yasheng Pharmaceutical Co., Ltd. International high-end original new small molecule targeted anti-tumor drug R&D and production project (Suzhou, Jiangsu) The project covers an area of 60,900 square meters and a total construction area of 150,000 square meters. The global new drug research and development center and production base of small molecule chemical preparations will be transferred to commercial drug production after the clinical trial is completed. The first phase of oral solid preparations is 130 million tablets, the second phase of lyophilized preparations is 1 million bottles, and the third phase of construction of oral solid and freeze-dried preparations After commercial-scale production, the production capacity of oral solids increased by 400 million tablets, and the freeze-dried preparations increased by 10 million bottles.
Ascentage Pharma settled in Suzhou Industrial Park in 2016. The foundation stone laying of the headquarters is the deepening of the company’s overall layout in the park. It is understood that the company’s headquarters covers an area of 95 acres. In the future, the main positioning of Ascentage Pharma’s global R&D center includes: expanding the design and optimization team of early-stage new target innovative drugs, further enriching the product pipeline; conducting in-depth translational medicine research, and conducting biomarker research, clinical pharmacology, precision medicine, and combination therapy to improve the success rate of clinical drug development. At the same time, it will also establish a global production base by international cGMP standards to provide strong support for the subsequent entry into the global pharmaceutical market.
2. Introduction to the contract of Suzhou Pharmaceutical R&D Center easy to operate Metal Expansion Joint
3. Introduction of Suzhou Pharmaceutical R&D Center easy to operate Metal Expansion Joint
Related links: Rubber expansion bellow product center From High-quality Rubber Expansion Bellow Manufacturer